Preclinical CROs in India: Advancing Drug Discovery & Development The preclinical CRO market in India is gaining significant momentum as pharmaceutical and biotechnology companies increasingly look to the country for cost-effective and high-quality preclinical research. Indian Contract Research Organizations (CROs) have emerged as pivotal players in the global drug discovery and development ecosystem. This blog delves into how preclinical CROs in India are driving innovation and supporting global healthcare advancements while adhering to USFDA and Good Laboratory Practices (GLP) standards. Growth of the Preclinical CRO Market in India The preclinical CRO market in India has witnessed remarkable growth over the past decade. Several factors contribute to this expansion, including: Cost Advantages: India offers substantial cost benefits compared to Western markets, making it an attractive destination for outsourcing preclinical research. Skilled Workforce: The country has a robust talent